Showing results (231-240 of 275) with videos related to

Sort By:
Pageof 28
Transplantation|June 21, 2024
Repeated COVID-19 Vaccination Drives Memory T- and B-cell Responses in Kidney Transplant Recipients: Results From a Multicenter Randomized Controlled TrialS Reshwan K Malahe, Yvette den Hartog, Wim J R Rietdijk, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 3, 2023
The role of interleukin-21 in COVID-19 vaccine-induced B cell-mediated immune responses in patients with kidney disease and kidney transplant recipientsS Reshwan K Malahe, Yvette den Hartog, Wim J R Rietdijk, et al.
The Lancet. Microbe|May 2, 2026
High-throughput multiplex immunoassay for the detection of mpox and MVA-BN vaccination up to 2 years after exposure in Belgium: a retrospective diagnostic accuracy studyJoachim Mariën, Christophe Van Dijck, Nicole Berens-Riha, et al.
Science Immunology|February 3, 2022
Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipientsCorine H GeurtsvanKessel, Daryl Geers, Katharina S Schmitz, et al.
Iscience|December 12, 2022
Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccinationDaryl Geers, Roos S G Sablerolles, Debbie van Baarle, et al.
Science Immunology|May 26, 2021
SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccineesDaryl Geers, Marc C Shamier, Susanne Bogers, et al.
The Lancet. Infectious Diseases|November 10, 2022
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trialMarcia M L Kho, A Lianne Messchendorp, Sophie C Frölke, et al.
Nature Communications|May 18, 2024
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boostersLuca M Zaeck, Ngoc H Tan, Wim J R Rietdijk, et al.
Transplantation|November 10, 2021
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney TransplantJan-Stephan F Sanders, Frederike J Bemelman, A Lianne Messchendorp, et al.
The Lancet. Infectious Diseases|April 23, 2023
Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trialNgoc H Tan, Daryl Geers, Roos S G Sablerolles, et al.
Pageof 28